Agreed. Waiting for deals on Asthma, CLI and Diabetic Ulcers as these are ready for partnering.
What's a partnering deal worth on each of these indications??
As per the companies last presentation:
"Valuable market opportunity: Estimated US$1.7bn revenue opportunity for MSC supplier for GvHD and CLI products alone"
Just for comparison below on market size.
GvHD
$USD 300m market size
$3m upfront (Fuji deal) alone
$60+m milestones
$30m p.a. royalties
CLI
$USD 1.4b market size (4.6x GvHD)
therefore approx
~$14m upfront
~$276+m milestones
~$138m p.a. royalties
Interesting times ahead
- Forums
- ASX - By Stock
- Ann: Positive 28-day Clinical Trial Data in Cohort B
Agreed. Waiting for deals on Asthma, CLI and Diabetic Ulcers as...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
25.5¢ |
Change
0.005(2.00%) |
Mkt cap ! $44.90M |
Open | High | Low | Value | Volume |
25.5¢ | 25.5¢ | 25.5¢ | $11 | 43 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8609 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.0¢ | 24001 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8609 | 0.260 |
4 | 17982 | 0.250 |
3 | 60076 | 0.245 |
3 | 105225 | 0.240 |
1 | 19148 | 0.235 |
Price($) | Vol. | No. |
---|---|---|
0.280 | 24001 | 2 |
0.295 | 183892 | 1 |
0.300 | 85000 | 2 |
0.310 | 16591 | 3 |
0.345 | 6124 | 1 |
Last trade - 10.02am 09/07/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |